Galdu-irabazien kontua
ABVC BIOPHARMA, INC.
ABVC
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY | Sep 30, 2015 2015 FY | Sep 30, 2014 2014 FY | Sep 30, 2013 2013 FY | Sep 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
0.03 | 0.51 | 0.15 | 0.97 | 0.36 | 0.48 | 0.70 | 0.52 | - | - | 0.00 | 0.00 | 0.01 | 0.01 |
|
Diru-sarreren kostua
|
0.00 | 0.00 | 0.30 | 0.29 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - |
|
Irabazi gordina
|
0.03 | 0.51 | 0.00 | 0.68 | 0.35 | 0.46 | 0.68 | 0.51 | - | 0.00 | 0.00 | - | 0.01 | 0.01 |
|
Ustiapen-gastuak
|
7.15 | 5.21 | 8.07 | 15.80 | 12.06 | 8.97 | 4.14 | 3.71 | 3.86 | 4.50 | 0.04 | 0.00 | 0.19 | 1.15 |
|
Ikerketa eta garapena
|
0.12 | 0.18 | 1.06 | 2.69 | 1.00 | 0.55 | 1.05 | 1.42 | 3.15 | - | - | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
2.89 | 2.26 | 5.37 | 6.07 | 5.75 | 4.27 | 3.07 | 2.26 | 0.71 | 4.50 | - | - | - | - |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-7.12 | -4.71 | -8.07 | -15.11 | -11.71 | -8.51 | -3.46 | -3.20 | -3.86 | -4.50 | -0.03 | 0.00 | -0.18 | -1.14 |
|
Ez-ustiapeneko diru-sarrerak
|
-1.20 | -0.66 | -2.44 | 0.40 | 0.50 | -2.31 | -0.55 | 0.01 | -0.07 | -0.01 | - | 0.00 | -0.05 | 0.14 |
|
Interesen diru-sarrerak
|
0.17 | 0.09 | 0.19 | 0.19 | - | 0.07 | 0.02 | 0.01 | 0.00 | 0.00 | - | - | - | - |
|
Interesen gastuak
|
0.01 | 0.02 | 2.49 | 0.29 | 0.23 | 0.41 | 0.48 | 0.46 | 0.07 | 0.01 | 0.00 | 0.00 | 0.05 | 0.09 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
-0.01 | -0.34 | -0.22 | - | 0.02 | 0.17 | -0.21 | -2.55 | - | - | - | - | - | - |
|
Zerga aurreko irabazia
|
-8.35 | -5.37 | -10.65 | -15.51 | -11.21 | -10.81 | -4.01 | -0.59 | -4.07 | -4.51 | - | - | - | - |
|
Zerga-gastua
|
-0.44 | -0.47 | -0.14 | 0.91 | 0.83 | -0.22 | -0.08 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.07 |
|
Partaidetza ez-kontrolatzailea
|
-0.47 | -0.36 | -0.39 | 0.11 | 0.80 | - | - | 0.49 | - | - | - | - | - | - |
|
Irabazi garbia
|
-7.91 | -4.90 | -10.52 | -16.42 | -12.04 | 10.59 | -3.93 | -4.10 | -4.07 | 4.51 | -0.03 | 0.00 | 0.00 | 0.00 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY | Sep 30, 2015 2015 FY | Sep 30, 2014 2014 FY | Sep 30, 2013 2013 FY | Sep 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-7.12 | -4.71 | -8.07 | -15.11 | -11.71 | -8.51 | -3.46 | -3.20 | -3.86 | -4.50 | -0.03 | 0.00 | -0.15 | -1.11 |
|
Akzioko irabazia (oinarrizkoa)
|
-0.39 | -0.42 | -2.43 | -0.52 | -0.51 | -0.50 | -0.21 | -0.02 | -0.02 | 0.02 | - | - | - | - |
|
EPS diluitua
|
-0.39 | -0.42 | -2.43 | - | -0.51 | -0.50 | -0.21 | -0.02 | -0.02 | 0.02 | - | - | - | - |
|
Akzioen batez besteko haztatua
|
20.11 | 11.67 | 4.34 | 31.66 | 25.05 | 19.72 | 17.50 | 213.88 | 212.65 | 193.98 | 5.00 | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
20.11 | 11.67 | 4.34 | - | 25.05 | 19.72 | 17.50 | 213.88 | 212.65 | 193.98 | - | - | - | - |
|
Irabazi globala
|
-7.87 | -4.97 | -10.52 | -16.45 | -12.86 | -9.89 | -3.63 | -0.59 | - | - | - | - | - | - |